Development of CAD for lung nodule screening |
Naïm Jalal |
GE HEALTHCARE |
NLST |
Oct 27, 2022 |
NLST-977 |
Alcohol Intake Across the Life Course and Risk of Ovarian Cancer in Postmenopausal Women |
Alexandra Schmidt |
University of North Dakota |
PLCO |
Oct 19, 2022 |
PLCO-1078 |
Survival analysis based on pathological images of lung cancer patients |
xiaofei xia |
Anhui University |
NLST |
Oct 19, 2022 |
NLST-976 |
Synthetic generation and tagging of CXR and pathology images |
Jonathan Pearson |
NHS Commissioning Board (NHS England) |
PLCO |
Oct 18, 2022 |
PLCOI-1077 |
Utilization of machine learning to create a predictive model for ovarian cancer based on pelvic ultrasound, CA-125, and clinical characteristics |
Graham Chapman |
Case Western Reserve University |
PLCO |
Oct 18, 2022 |
PLCO-1074 |
Global metabolomics profiling, dietary factors, and colorectal cancer risk in the NIHConsortium of Metabolomics Studies (COMETS) |
Jennifer Ose |
University of Utah |
PLCO |
Oct 18, 2022 |
PLCO-1067 |
Impact of Data Driven Decision Making in Healthcare Analytic |
May Myat |
University of Technology, Yatanarpon Cyber City(UTYCC), Pyin Oo Lwin, Myanmar |
PLCO |
Oct 18, 2022 |
PLCO-1064 |
Mathematical modelling of prostate cancer data |
Taylor deVet |
McMaster University |
PLCO |
Oct 18, 2022 |
PLCO-1073 |
Time Lag to Benefit: A Systematic Review and Meta-Analysis of Lung Cancer Screening Trials |
Alison Rustagi |
University of California, San Francisco |
NLST |
Oct 18, 2022 |
NLST-972 |
Machine Learning Analysis for Lung Cancer Progression |
Anderson Nnewihe |
Johnson & Johnson Enterprise Innovation, Inc. |
NLST |
Oct 18, 2022 |
NLST-973 |
Early diagnosis of lung cancer based on imbalance class data |
Xiaowen Yang |
Chongqing University of Posts and Telecommunications |
NLST |
Oct 18, 2022 |
NLST-967 |
Lung Nodule Malignancy Classification Based On Time-Series Model |
Chaoran Jia |
Dalian University of Technology |
NLST |
Oct 18, 2022 |
NLST-969 |
Risk-stratified multi-round PSA screening for prostate cancer incorporating population-based screening reference level and subgroup-specific progression indicators |
Huang Yubei |
Tianjin Medical University Cancer Institute and Hospital |
PLCO |
Oct 11, 2022 |
PLCO-1072 |
Causal inference with incomplete compliance or outcomes truncated by death |
Aixian Chen |
School of Economics and Statistics, Guangzhou University, Guangzhou, China |
PLCO |
Oct 11, 2022 |
PLCO-1069 |
Integrating multi-omics information to explore disease processes |
Tiantian Sun |
Shandong University |
PLCO |
Oct 11, 2022 |
PLCO-1060 |
Looking for the retrospective link between cigarette habits in men and prostate cancer |
Tamara yaghi |
American international School of riyadh |
PLCO |
Oct 11, 2022 |
PLCO-1071 |
The association of the sulfur microbial diet with colorectal adenoma and recurrent adenoma risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Linglong Peng |
The Second Affiliated Hospital of Chongqing Medical University |
PLCO |
Oct 11, 2022 |
PLCO-1070 |
PREDICTED MORTALITY AS A SURROGATE ENDPOINT IN THE PLCO TRIAL |
Matejka Rebolj |
Queen Mary University of London |
PLCO |
Oct 11, 2022 |
PLCO-1066 |
Comparative analysis of the cost-effectiveness and implementation of lung cancer screening with LDCT in the US and EU |
Tanya Rajabi |
Semmelweis University |
NLST |
Oct 11, 2022 |
NLST-968 |
Lung cancer risk assessment |
Adam Vasserstrom |
Nucleix |
NLST |
Oct 11, 2022 |
NLST-965 |